Market overview
The global continuous positive airway pressure (CPAP) market is worth USD 3.1 bn in 2026 and is forecast to reach USD 5.8 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Auto-adjusting CPAP is the largest by device type segment.
| Scope | Continuous positive airway pressure devices for sleep apnoea: fixed-pressure, auto-adjusting and travel CPAP units sold for home, sleep lab and hospital use. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.9 bn |
| Value 2026 | USD 3.1 bn |
| Value 2036 | USD 5.8 bn |
| CAGR 2026-2036 | 6.5% |
| Volume 2026 | 5.91 million units |
| Volume 2036 | 10.6 million units |
| Average price 2026 | USD 520 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Continuous Positive Airway Pressure (CPAP) market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.1 bn |
| 2027 | USD 3.3 bn |
| 2028 | USD 3.5 bn |
| 2029 | USD 3.7 bn |
| 2030 | USD 4.0 bn |
| 2031 | USD 4.2 bn |
| 2032 | USD 4.5 bn |
| 2033 | USD 4.8 bn |
| 2034 | USD 5.1 bn |
| 2035 | USD 5.4 bn |
| 2036 | USD 5.8 bn |
Continuous Positive Airway Pressure (CPAP) market segmentation
By device type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Auto-adjusting CPAP | 52.0% | 53.0% | USD 1.6 bn | 6.7% |
| Fixed-pressure CPAP | 36.0% | 27.6% | USD 1.1 bn | 3.7% |
| Travel and compact CPAP | 12.0% | 19.4% | USD 369 mn | 11.7% |
By setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Home | 80.0% | 83.1% | USD 2.5 bn | 6.9% |
| Sleep clinics and labs | 12.0% | 10.5% | USD 369 mn | 5.1% |
| Hospitals | 8.0% | 6.4% | USD 246 mn | 4.1% |
By mode
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fixed pressure CPAP | 30.0% | 24.0% | USD 922 mn | 4.2% |
| Auto-adjusting CPAP | 54.0% | 56.0% | USD 1.7 bn | 6.9% |
| Bi-level and others | 16.0% | 20.0% | USD 492 mn | 8.9% |
By interface
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nasal masks | 38.0% | 38.0% | USD 1.2 bn | 6.5% |
| Full face masks | 28.0% | 28.0% | USD 861 mn | 6.5% |
| Nasal pillows | 20.0% | 20.0% | USD 615 mn | 6.5% |
| Accessories and tubing | 14.0% | 14.0% | USD 430 mn | 6.5% |
By channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Home care dealers | 52.0% | 48.0% | USD 1.6 bn | 5.7% |
| Hospitals and sleep clinics | 24.0% | 22.0% | USD 738 mn | 5.6% |
| Online and direct | 24.0% | 30.0% | USD 738 mn | 8.9% |
Top 25 countries for continuous positive airway pressure (CPAP) by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.5% of 2026 revenue and the 25 countries below together hold 96.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.4 bn | 44.0% | USD 2.6 bn | 6.5% |
| 2 | China | USD 246 mn | 8.0% | USD 560 mn | 8.6% |
| 3 | Germany | USD 215 mn | 7.0% | USD 369 mn | 5.5% |
| 4 | Japan | USD 154 mn | 5.0% | USD 254 mn | 5.2% |
| 5 | France | USD 154 mn | 5.0% | USD 265 mn | 5.6% |
| 6 | United Kingdom | USD 123 mn | 4.0% | USD 219 mn | 6.0% |
| 7 | Australia | USD 92 mn | 3.0% | USD 173 mn | 6.5% |
| 8 | Canada | USD 92 mn | 3.0% | USD 167 mn | 6.1% |
| 9 | Italy | USD 77 mn | 2.5% | USD 127 mn | 5.2% |
| 10 | Brazil | USD 61 mn | 2.0% | USD 127 mn | 7.5% |
| 11 | Netherlands | USD 60 mn | 1.9% | USD 110 mn | 6.3% |
| 12 | Spain | USD 47 mn | 1.5% | USD 86 mn | 6.3% |
| 13 | Belgium | USD 38 mn | 1.2% | USD 69 mn | 6.2% |
| 14 | Switzerland | USD 34 mn | 1.1% | USD 63 mn | 6.3% |
| 15 | Sweden | USD 33 mn | 1.1% | USD 61 mn | 6.2% |
| 16 | Mexico | USD 33 mn | 1.1% | USD 68 mn | 7.6% |
| 17 | India | USD 29 mn | 0.9% | USD 59 mn | 7.5% |
| 18 | Russia | USD 22 mn | 0.7% | USD 45 mn | 7.5% |
| 19 | Turkey | USD 21 mn | 0.7% | USD 43 mn | 7.6% |
| 20 | Israel | USD 20 mn | 0.6% | USD 36 mn | 6.2% |
| 21 | Denmark | USD 17 mn | 0.6% | USD 32 mn | 6.3% |
| 22 | Austria | USD 13 mn | 0.4% | USD 24 mn | 6.2% |
| 23 | Saudi Arabia | USD 11 mn | 0.4% | USD 22 mn | 7.4% |
| 24 | Taiwan | USD 10 mn | 0.3% | USD 22 mn | 7.7% |
| 25 | Poland | USD 8.9 mn | 0.3% | USD 18 mn | 7.5% |
| Rest of world | USD 111 mn | 3.6% | USD 200 mn | 6.0% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- ResMed
- Philips
- Fisher & Paykel Healthcare
Group 2: Regional and specialist players
- React Health
- BMC Medical
- Loewenstein Medical
- Breas Medical
- Drive DeVilbiss Healthcare
- Sefam
- Teijin Pharma
- Hoffrichter
Group 3: Emerging and niche players
- Resvent
- Apex Medical
- Yuwell
- Somnetics International
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the continuous positive airway pressure (CPAP) market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.
The market is divided by device type, by setting, by mode, by interface, by channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the continuous positive airway pressure (CPAP) market?
The global continuous positive airway pressure (CPAP) market is estimated at USD 2.9 bn in 2025 and USD 3.1 bn in 2026.
How fast will the continuous positive airway pressure (CPAP) market grow?
It is forecast to reach USD 5.8 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 2.7 bn.
Which country is the largest market for continuous positive airway pressure (CPAP)?
United States is the largest market by revenue at USD 1.4 bn in 2026, 44.0% of the global total. The three largest countries together hold 59.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.6% a year from 2026 to 2036.
Which continuous positive airway pressure (CPAP) segment is largest?
In the by device type split, Auto-adjusting CPAP is the largest segment with 52.0% of 2026 revenue.
Who are the leading continuous positive airway pressure (CPAP) companies?
Global leaders include ResMed, Philips, Fisher & Paykel Healthcare.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Enzyme Linked Immunosorbent AssayUSD 3.1 bn · 5.2% CAGR
- Spray DryingUSD 3.0 bn · 5.3% CAGR
- Lyophilization EquipmentUSD 3.1 bn · 7.6% CAGR
- BiobankingUSD 3.2 bn · 8.5% CAGR
- CRISPR and Cas GeneUSD 2.9 bn · 13.5% CAGR
- Neurorehabilitation TechnologyUSD 3.4 bn · 9.0% CAGR
- CapsuleUSD 3.4 bn · 6.5% CAGR
- Gene SynthesisUSD 2.8 bn · 15.0% CAGR
← Continuous Peripheral Nerve Block Catheter Contract Development and Manufacturing Organization →